Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.
Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Pénzes I, Kübler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM; KyberSept Trial Study Group.
Warren BL, et al.
JAMA. 2001 Oct 17;286(15):1869-78. doi: 10.1001/jama.286.15.1869.
JAMA. 2001.
PMID: 11597289
Clinical Trial.